** Shares of telehealth platform Hims & Hers HIMS.N fall 5.1% to $44.72 in extended trading
** The U.S. Federal Trade Commission is probing complaints about HIMS' advertising and cancellation practices, Bloomberg News reports, citing people familiar with the matter
** The company previously said it was cooperating with an unspecified FTC investigation after the agency demanded information from the company in October 2023
** Stock up 94.9% YTD